JAK/STAT inhibition reprograms T cell activation and metabolism in inflammatory arthritis patients
Viviana Marzaioli, Aenea A. I. Brugman, Niamh O’Dowd, Achilleas Floudas, Aine Gorman, Carl Orr, Douglas J. Veale, Ursula Fearon · 2026
Read JAK/STAT inhibition reprograms T cell activation and metabolism in inflammatory arthritis patients by Viviana Marzaioli, Aenea A. I. Brugman, Niamh O’Dowd, Achilleas Floudas, Aine Gorman, Carl Orr, Douglas J. Veale, Ursula Fearon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144226.txt.
Description
Marzaioli and seven co-authors present a study from twenty twenty-six on how a joint drug reshapes T cells in inflammatory arthritis. The drug blocks a signaling path used by immune cells. Its direct effects on T cells were widely unknown. The team study T cells from blood, joint fluid, and joint tissue of patients. Lab tests measure activation, growth, and energy use under the drug. Shaping of naive cells into helper types is also tracked. The drug cuts helper cell activation sharply across sample types.
Treated cells show less harmful multi-signal output as well. Shifts toward all three helper types fall under the drug. Energy use switches, mainly in killer T cells. The authors say the drug limits T cell harm in blood and joints.
Catalog record
| CREATOR | Viviana Marzaioli, Aenea A. I. Brugman, Niamh O’Dowd, Achilleas Floudas, Aine Gorman, Carl Orr, Douglas J. Veale, Ursula Fearon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |